Global Personalized Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Personalized Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts" report to their offering.

Global Personalized Medicine Partnering 2010 to 2017 provides the full collection of Personalized Medicine disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Personalized Medicine disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Personalized Medicine deals.

Global Personalized Medicine Partnering 2010 to 2017 includes:

  • Trends in Personalized Medicine dealmaking in the biopharma industry since 2010
  • Analysis of Personalized Medicine deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Personalized Medicine deal contract documents
  • Comprehensive access to over 3500 Personalized Medicine deal records
  • The leading Personalized Medicine deals by value since 2010
  • Most active Personalized Medicine dealmakers since 2010

In Global Personalized Medicine Partnering 2010 to 2017, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in Personalized Medicine dealmaking

Chapter 3 -Financial deal terms for Personalized Medicine partnering

Chapter 4 - Leading Personalized Medicine deals and dealmakers

Chapter 5 - Personalized Medicine contract document directory

Chapter 6 - Personalized Medicine dealmaking by therapeutic target

For more information about this report visit http://www.researchandmarkets.com/research/fmjt38/global

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics